These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16556844)

  • 1. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
    Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Nishio J; Gaglia JL; Turvey SE; Campbell C; Benoist C; Mathis D
    Science; 2006 Mar; 311(5768):1775-8. PubMed ID: 16556845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
    Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
    Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunology. Diabetes studies conflict on power of spleen cells.
    Couzin J
    Science; 2006 Mar; 311(5768):1694. PubMed ID: 16556811
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of type 1 diabetes in mice.
    Melton DA
    N Engl J Med; 2006 Jul; 355(1):89-90. PubMed ID: 16823003
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice.
    Faustman DL; Tran SD; Kodama S; Lodde BM; Szalayova I; Key S; Toth ZE; Mezey E
    Science; 2006 Nov; 314(5803):1243; author reply 1243. PubMed ID: 17124308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice].
    Wang XX; Niu XH; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):105-7. PubMed ID: 12575330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplastic islets observed in "reversed" NOD mice treated without hematopoietic cells.
    Okubo Y; Shimada A; Kanazawa Y; Shigihara T; Oikawa Y; Imai T; Miyazaki J; Itoh H
    Diabetes Res Clin Pract; 2008 Jan; 79(1):18-23. PubMed ID: 17919765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed chimerism and growth factors augment β cell regeneration and reverse late-stage type 1 diabetes.
    Wang M; Racine JJ; Song X; Li X; Nair I; Liu H; Avakian-Mansoorian A; Johnston HF; Liu C; Shen C; Atkinson M; Todorov I; Kandeel F; Forman S; Wilson B; Zeng D
    Sci Transl Med; 2012 May; 4(133):133ra59. PubMed ID: 22572882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diabetic NOD mice using adjuvant therapy.
    Lakey JR; Wang T; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1992 Dec; 24(6):2848. PubMed ID: 1465969
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes results from a late change in the autoimmune response of NOD mice.
    Gazda LS; Charlton B; Lafferty KJ
    J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice.
    Gao X; Song L; Shen K; Wang H; Niu W; Qin X
    Biochem Biophys Res Commun; 2008 Jun; 371(1):132-7. PubMed ID: 18420028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function.
    Ryu S; Kodama S; Ryu K; Schoenfeld DA; Faustman DL
    J Clin Invest; 2001 Jul; 108(1):63-72. PubMed ID: 11435458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.